OABI Competitors & Alternatives
Compare OmniAb Inc. with similar stocks in the same industry
Biotechnology
OABI
Main Stock$2.65
Tradestie Score
58
Market Cap
$231.77M
Revenue Growth
2.5%
Analyst Upside
+176.7%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.97
|
$386.68M | - | 52 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.60
|
$382.04M | - | 48 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$10.04
|
$371.64M | - | 58 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$28.87
|
$357.51M | - | 53 | Compare |
|
LRMR
Larimar Therapeutics, Inc. Common Stock
|
$3.45
|
$355.20M | - | 51 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$13.84
|
$354.45M | - | 53 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$28.12
|
$353.70M | - | 56 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.75
|
$350.98M | - | 50 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.90
|
$341.56M | - | 64 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.31
|
$332.96M | - | 55 | Compare |
More OABI Analysis
Data updated: May 25, 2026 | Industry: Biotechnology (SIC 8731)
226 stocks in this industry